AN2 Therapeutics, Inc. (ANTX) Tops Q2 EPS by 13c

AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q2 EPS of ($0.48), $0.13 better than the analyst estimate of ($0.61).

For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.

You May Also Be Interested In

• CrowdStrike shares jump on earnings beat, raised outlook
• Ooma (OOMA) Tops Q2 EPS by 2c; offers guidance
• Goldman Sachs Downgrades Poly Property Services Co Ltd (6049:HK) to Neutral